Within a day of testing positive for covid-19 in June, Miranda Kelly was sick enough to be scared. At 44,
Continue reading »
Home »
FDA Approves Trudhesa
FDA Approves Trudhesa (dihydroergotamine mesylate) Nasal Spray for the Acute Treatment of Migraine SEATTLE, Sept. 03, 2021 (GLOBE NEWSWIRE) —
Continue reading »
Hot Spots Where Covid Vaccination Lags Push Experimental Antibody Treatment
For months, Joelle Ruppert was among the millions of Americans who are covid vaccine holdouts. Her reluctance, she said, was
Continue reading »
The White House Says Boosters for All. Here’s What You Need to Know.
[UPDATED at 3 p.m. ET to reflect news developments] The Biden administration announced plans Wednesday to offer boosters to all
Continue reading »
Pfizer CEO to Public: Just Trust Us on the Covid Booster
Pfizer CEO Albert Bourla was confident in June about the ability of his company’s vaccine to protect against the highly
Continue reading »
FDA Approves Semglee (insulin glargine-yfgn) as First Interchangeable Biosimilar Insulin Product for Treatment of Diabetes
SILVER SPRING, Md., July 28, 2021 /PRNewswire/ — Today, the U.S. Food and Drug Administration approved the first interchangeable biosimilar insulin product,
Continue reading »
FDA Approves Rybrevant
FDA Approves Rybrevant (amivantamab-vmjw) as the First Targeted Treatment for Patients with Non-Small Cell Lung Cancer with EGFR Exon 20
Continue reading »
FDA Approves Xolair (omalizumab) Prefilled Syringe for Self-Injection Across All Indications
South San Francisco, CA — April 12, 2021 — Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX:
Continue reading »
FDA Approves Kimyrsa
FDA Approves Kimyrsa (oritavancin) for the Treatment of Adult Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI) MORRISTOWN,
Continue reading »
FDA Approves Cosela
FDA Approves Cosela (trilaciclib) to Decrease the Incidence of Chemotherapy-Induced Myelosuppression RESEARCH TRIANGLE PARK, N.C., Feb. 12, 2021 (GLOBE NEWSWIRE)
Continue reading »